Cargando…

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

INTRODUCTION: Oligomeric amyloid-ß is a major toxic species associated with Alzheimer’s disease pathogenesis. Methods used to measure oligomeric amyloid-β in the blood have increased in number in recent years. The Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) is a specific method to measu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youn, Young Chul, Kang, Sungmin, Suh, Jeewon, Park, Young Ho, Kang, Min Ju, Pyun, Jung-Min, Choi, Seong Hye, Jeong, Jee Hyang, Park, Kyung Won, Lee, Ho-Won, An, Seong Soo A., Dominguez, Jacqueline C., Kim, SangYun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511146/ https://www.ncbi.nlm.nih.gov/pubmed/31077246 http://dx.doi.org/10.1186/s13195-019-0499-7

Ejemplares similares

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data
por: Youn, Young Chul, et al.
Publicado: (2022)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ(42)
por: An, Seong Soo A., et al.
Publicado: (2017)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
por: Wang, Min Jeong, et al.
Publicado: (2017)

Coping with Dementia in the Middle of the COVID-19 Pandemic
por: Ryoo, Nayoung, et al.
Publicado: (2020)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
por: Babapour Mofrad, Rosha, et al.
Publicado: (2021)

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
por: Shim, Kyu Hwan, et al.
Publicado: (2020)

Misplacement of something inside the refrigerator is not a sign of dementia, but a probable symptom of attention deficit due to depression
por: Suh, Jeewon, et al.
Publicado: (2021)

Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment
por: Chun, Min Young, et al.
Publicado: (2022)

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2018)

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2023)

Pathogenic PSEN1 Thr119Ile Mutation in Two Korean Patients with Early-Onset Alzheimer’s Disease
por: Bagyinszky, Eva, et al.
Publicado: (2020)

Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease
por: Park, Young Ho, et al.
Publicado: (2021)

PET-validated EEG-machine learning algorithm predicts brain amyloid pathology in pre-dementia Alzheimer’s disease
por: Kim, Nam Heon, et al.
Publicado: (2023)

Differences between memory encoding and retrieval failure in mild cognitive impairment: results from quantitative electroencephalography and magnetic resonance volumetry
por: Han, Su-Hyun, et al.
Publicado: (2021)

Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study
por: Hong, Yun Jeong, et al.
Publicado: (2023)

A ‘Comprehensive Visual Rating Scale’ for predicting progression to dementia in patients with mild cognitive impairment
por: Jang, Jae-Won, et al.
Publicado: (2018)

Electroencephalography for Early Detection of Alzheimer’s Disease in Subjective Cognitive Decline
por: Shim, YongSoo, et al.
Publicado: (2022)

Study Design and Baseline Results in a Cohort Study to Identify Predictors for the Clinical Progression to Mild Cognitive Impairment or Dementia From Subjective Cognitive Decline (CoSCo) Study
por: Ho, SeongHee, et al.
Publicado: (2022)

(11)C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn, Young Chul, et al.
Publicado: (2017)

Clinical Significance of Physical Frailty in Subjects With Subjective Cognitive Decline: A Prospective Study With Amyloid PET Data
por: Lim, Eun Ye, et al.
Publicado: (2023)

Early Onset Alzheimer's Disease Presenting as Logopenic Primary Progressive Aphasia
por: Oh, Mi Jin, et al.
Publicado: (2018)

Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Predictors of pre-operative cognitive impairment in meningioma patients over 60 years old
por: Kang, Min Ju, et al.
Publicado: (2020)

Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease
por: Koh, Seong-Ho, et al.
Publicado: (2020)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
por: Shim, Kyu Hwan, et al.
Publicado: (2022)

Survival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and Parkinsonism
por: Jung, Na-Yeon, et al.
Publicado: (2022)

Radiating Amyloid Fibril Formation on the Surface of Lipid Membranes through Unit-Assembly of Oligomeric Species of α-Synuclein
por: Lee, Jung-Ho, et al.
Publicado: (2012)

Serum albumin and beta-amyloid deposition in the human brain
por: Kim, Jee Wook, et al.
Publicado: (2020)

A Comparative Evaluation of the KDSQ-C, AD8, and SMCQ as a Cognitive Screening Test to Be Used in National Medical Check-ups in Korea
por: Kim, Ahro, et al.
Publicado: (2019)

Reliability and Validity of a Short Form of the Korean Dementia Screening Questionnaire-Cognition
por: Kim, Ahro, et al.
Publicado: (2020)

Use of the Clock Drawing Test and the Rey–Osterrieth Complex Figure Test-copy with convolutional neural networks to predict cognitive impairment
por: Youn, Young Chul, et al.
Publicado: (2021)

Extranodal NK/T-Cell Lymphoma Mimicking an Infectious Granuloma
por: Suh, Min Song, et al.
Publicado: (2019)

Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology
por: Pyun, Jung‐Min, et al.
Publicado: (2022)

Predicting progression to dementia with “comprehensive visual rating scale” and machine learning algorithms
por: Park, Chaeyoon, et al.
Publicado: (2022)

Expression of nucleotide-binding oligomerization domain 1 and 2 in oral lichen planus
por: Ahn, Mee-Young, et al.
Publicado: (2020)

Cost-effectiveness of Pharmaceutical Interventions to Prevent Osteoporotic Fractures in Postmenopausal Women with Osteopenia
por: Kwon, Jin-Won, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bhofjd17o9mi7ll849jna7mcqg